BACKGROUND Lymph node metastasis (LNM) affects the application and outcomes of
endoscopic resection in T1 esophageal squamous cell carcinoma (ESCC). However, reports …

Barrett's esophagus is a metaplastic change of esophageal mucosa, which can be
characterized by its salmon-colored lining and the presence of columnar epithelium with …

Background and Aims The treatment of submucosal (T1b) esophageal adenocarcinoma
(EAC) remains in evolution, with some evidence supporting endoscopic management of low …

Endoscopic eradication therapy (EET) has become a standard of care for treatment of
dysplastic Barrett's esophagus (BE) and early Barrett's neoplasia. EET mainly consists of …

Methods A previously published systematic review on this topic included publications
between 8/2001 and 8/2016 and had identified 24 relevant publications. 3 The authors …

Introduction Endoscopic therapy (ET) and esophagectomy result in similar survival for
Barrett's esophagus (BE) with high-grade dysplasia (HGD) or T1a esophageal …

Background Esophageal cancer causes considerable costs for health systems. Appropriate
treatment options for patients with esophageal squamous cell carcinoma (ESCC) can …

Barrett's esophagus (BE) with high‐grade dysplasia (HGD) has previously been a routine
indication for esophagectomy. Recent advances in endoscopic therapy have resulted in a …

Background and Aims Limited data exist regarding the long-term outcomes of endoscopic
therapy (ET) with or without chemoradiation therapy (CRT) for T1b esophageal …

Background: Studies on economic burden demonstrate the impacts of some diseases and
provide invaluable information for specifying priorities and resource needs when designing …